• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H5N1疫苗的现状以及雪貂模型在流感治疗和预防研发中的应用。

The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development.

作者信息

Banner David, Kelvin Alyson A

机构信息

Division of Experimental Therapeutics, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.

出版信息

J Infect Dev Ctries. 2012 Jun 15;6(6):465-9. doi: 10.3855/jidc.2666.

DOI:10.3855/jidc.2666
PMID:22706187
Abstract

Highly pathogenic avian influenza H5N1 is a threat to global public health as a natural pandemic causing agent but has recently been considered a bioterrorism concern.  The evolving view of the H5N1 virus necessitates the re-evaluation of the current status of H5N1 therapeutics and prophylactics, in particular the preparation of viable H5N1 vaccination strategies as well as the use of ferrets in influenza research.  Here the highly pathogenic H5N1 virus dilemma is discussed in context with the current H5N1 vaccine status and the use of the ferret model.  Previously, the development of various H5N1 vaccine platforms have been attempted, many of them tested in the ferret model, including vector vaccines, adjuvant vaccines, DNA vaccines, and reverse engineered vaccines. Moreover, as ferrets are a superlative animal model for influenza investigation and vaccine testing, it is imperative that this model is recognized for its uses in prophylactic development and not only as an agent for creating transmissible influenza viruses.  Elucidating the ferret immune response and creating ferret immune reagents remain important goals in conjunction with the development and manufacture of H5N1 vaccines.  In summary, an efficacious H5N1 vaccine is urgently needed and the ferret model remains an appropriate model for its development.

摘要

高致病性禽流感H5N1作为一种自然大流行致病因子,对全球公共卫生构成威胁,但最近被视为生物恐怖主义问题。对H5N1病毒不断演变的看法使得有必要重新评估H5N1治疗药物和预防药物的现状,特别是制定可行的H5N1疫苗接种策略以及在流感研究中使用雪貂。本文结合当前H5N1疫苗的现状和雪貂模型的使用,讨论了高致病性H5N1病毒的困境。此前,人们尝试开发了各种H5N1疫苗平台,其中许多在雪貂模型中进行了测试,包括载体疫苗、佐剂疫苗、DNA疫苗和反向工程疫苗。此外,由于雪貂是流感研究和疫苗测试的最佳动物模型,必须认识到该模型在预防性开发中的用途,而不仅仅是作为制造可传播流感病毒的工具。阐明雪貂的免疫反应并制备雪貂免疫试剂,仍然是与H5N1疫苗的开发和生产相关的重要目标。总之,迫切需要一种有效的H5N1疫苗,而雪貂模型仍然是其开发的合适模型。

相似文献

1
The current state of H5N1 vaccines and the use of the ferret model for influenza therapeutic and prophylactic development.H5N1疫苗的现状以及雪貂模型在流感治疗和预防研发中的应用。
J Infect Dev Ctries. 2012 Jun 15;6(6):465-9. doi: 10.3855/jidc.2666.
2
Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.用植物源H5 HA疫苗进行鼻内接种可保护小鼠和雪貂免受高致病性禽流感病毒攻击。
Hum Vaccin Immunother. 2015;11(5):1235-43. doi: 10.4161/21645515.2014.988554.
3
Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.基于神经氨酸酶的重组病毒样颗粒可保护雪貂免受致死性甲型禽流感病毒(H5N1)感染。
Virology. 2017 Sep;509:90-97. doi: 10.1016/j.virol.2017.06.006. Epub 2017 Jun 16.
4
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.新型活流感疫苗M2SR可保护小鼠和雪貂免受高致病性禽流感的侵害。
Vaccine. 2017 Jul 24;35(33):4177-4183. doi: 10.1016/j.vaccine.2017.06.039. Epub 2017 Jun 28.
5
Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.针对快速进化的H5亚型病毒开发具有分支特异性和广泛反应性的减毒活流感病毒疫苗。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00547-17. Print 2017 Aug 1.
6
The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants.水包油佐剂在雪貂模型中评估禽流感 H5N1 疫苗免疫保护相关性。
Sci Rep. 2017 Mar 17;7:44727. doi: 10.1038/srep44727.
7
Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models.评估通过主动感染人季节性甲型流感病毒或三价灭活疫苗免疫在雪貂模型中对高致病性 H5N1 的异源交叉保护作用。
J Gen Virol. 2014 Apr;95(Pt 4):793-798. doi: 10.1099/vir.0.058636-0. Epub 2014 Jan 13.
8
Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.含铝佐剂的灭活H5N1全病毒疫苗在小鼠模型中可诱导针对高致病性H5N1禽流感病毒致死性攻击的同源和异源保护性免疫。
Vaccine. 2007 May 4;25(18):3554-60. doi: 10.1016/j.vaccine.2007.01.083. Epub 2007 Jan 30.
9
Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.长期疫苗诱导的对雪貂模型中 H5N1 流感病毒的异源保护作用。
Influenza Other Respir Viruses. 2013 Jul;7(4):506-12. doi: 10.1111/j.1750-2659.2012.00423.x. Epub 2012 Aug 16.
10
IgG antibodies mediate protective immunity of inactivated vaccine for highly pathogenic H5N1 influenza viruses in ferrets.IgG 抗体介导了针对高致病性 H5N1 流感病毒的灭活疫苗在雪貂中的保护性免疫。
Viral Immunol. 2010 Jun;23(3):321-7. doi: 10.1089/vim.2009.0093.

引用本文的文献

1
Host Transcriptome Analysis of Ferret Tissues Following Henipavirus Infection.雪貂组织感染亨德拉病毒后的宿主转录组分析。
Methods Mol Biol. 2023;2682:281-299. doi: 10.1007/978-1-0716-3283-3_20.
2
Evaluation of a New Viral Vaccine Vector in Mice and Rhesus Macaques: J Paramyxovirus Expressing Hemagglutinin of Influenza A Virus H5N1.甲型 H5N1 流感病毒血凝素的副黏病毒在小鼠和食蟹猕猴中的评估。
J Virol. 2021 Oct 27;95(22):e0132121. doi: 10.1128/JVI.01321-21. Epub 2021 Sep 1.
3
Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.
在雪貂感染 SARS-CoV-2 期间,性和年龄偏见病毒载量和干扰素反应。
Sci Rep. 2021 Jul 15;11(1):14536. doi: 10.1038/s41598-021-93855-9.
4
The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.年龄与流感严重程度的交集:雪貂在剖析年龄相关免疫反应中的作用及其与年龄特异性疫苗开发的相关性。
Viruses. 2021 Apr 15;13(4):678. doi: 10.3390/v13040678.
5
Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets.在雪貂感染新冠病毒期间,性别和年龄对病毒载量、病毒脱落以及1型和2型干扰素反应存在偏向性影响。
bioRxiv. 2021 Jan 12:2021.01.12.426381. doi: 10.1101/2021.01.12.426381.
6
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.预防性鼻腔内给予 TLR2/6 激动剂可减少 SARS-CoV-2 挑战雪貂模型的上呼吸道病毒脱落。
EBioMedicine. 2021 Jan;63:103153. doi: 10.1016/j.ebiom.2020.103153. Epub 2020 Dec 3.
7
Host gene expression profiles in ferrets infected with genetically distinct henipavirus strains.雪貂感染遗传特性不同亨德拉尼帕病毒株后的宿主基因表达谱。
PLoS Negl Trop Dis. 2018 Mar 14;12(3):e0006343. doi: 10.1371/journal.pntd.0006343. eCollection 2018 Mar.
8
Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets.用异源串联重复M2e5x病毒样颗粒补充2009年甲型H1N1流感裂解疫苗可增强雪貂的交叉保护作用。
Vaccine. 2016 Jan 20;34(4):466-473. doi: 10.1016/j.vaccine.2015.12.023. Epub 2015 Dec 19.
9
Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets.乙型流感病毒的小鼠适应性增强了其在上呼吸道的复制,并导致在雪貂中通过飞沫传播。
Sci Rep. 2015 Nov 3;5:15940. doi: 10.1038/srep15940.
10
Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.基质M H5N1疫苗在一项随机临床试验中诱导交叉H5分支体液免疫反应,并为雪貂提供针对高致病性流感攻击的保护。
PLoS One. 2015 Jul 6;10(7):e0131652. doi: 10.1371/journal.pone.0131652. eCollection 2015.